Back to Search Start Over

Effect of cardiac stem cells on left-ventricular remodeling in a canine model of chronic myocardial infarction.

Authors :
Welt FG
Gallegos R
Connell J
Kajstura J
D'Amario D
Kwong RY
Coelho-Filho O
Shah R
Mitchell R
Leri A
Foley L
Anversa P
Pfeffer MA
Source :
Circulation. Heart failure [Circ Heart Fail] 2013 Jan; Vol. 6 (1), pp. 99-106. Date of Electronic Publication: 2012 Dec 04.
Publication Year :
2013

Abstract

Background: Regenerative medicine, including cell therapy, is a promising strategy for recovery of the damaged myocardium. C-kit-positive cardiac stem cells (CSCs) have been shown to improve myocardial function after ischemic injury in animal models and in early clinical experience. We used a chronic large animal model of myocardial infarction with substantial reductions in left-ventricular (LV) ejection fraction and adverse remodeling to examine the effect of late autologous CSC intramyocardial injection on long-term cardiac structure and function.<br />Methods and Results: Thoracotomy and ligation of the proximal left anterior descending artery, additional diagonal branches, and atrial biopsy for CSC culture were performed in canines. Baseline cardiac MRI was performed at 6 weeks postinfarct followed by repeat thoracotomy for randomization to intramyocardial injection of CSCs (n=13) or vehicle alone (n=6). At 30 weeks postmyocardial infarction, repeat MRI was performed. Data were analyzed using nonparametric tests (Wilcoxon signed-rank and rank-sum tests). In control animals, LV end-systolic volume and end-diastolic volume increased from 6 to 30 weeks (median and interquartile range, 51.3 mL [43.3-57.4] to 76.1 mL [72.0-82.4]; P=0.03 and 78.5 mL [69.7-86.1] to 99.2 mL [97.1-100.4]; P=0.03). Left-ventricular ejection fraction declined further (35.2% [27.9-38.7] to 26.4% [22.0-31.0]; P=0.12). In the cell-treated animals, this late adverse LV remodeling was attenuated (LV end-systolic volume, 42.6 mL [38.5-50.5] to 56.1 mL [50.3-63.0]; P=0.01 versus control). There was a nonsignificant attenuation in the increase in LV end-diastolic volume (64.8 mL [60.7-71.3] to 83.5 mL [74.7-90.8]; P=0.14 versus control) and LV ejection fraction change over time differed (30.5% [28.4-33.4] to 32.9% [28.6-36.9]; P=0.04 versus control).<br />Conclusions: Intramyocardial injection of autologous CSCs in a late phase model of chronic infarction resulted in less increase in LV end-systolic volume and preservation of LV ejection fraction.

Details

Language :
English
ISSN :
1941-3297
Volume :
6
Issue :
1
Database :
MEDLINE
Journal :
Circulation. Heart failure
Publication Type :
Academic Journal
Accession number :
23212553
Full Text :
https://doi.org/10.1161/CIRCHEARTFAILURE.112.972273